首页 > 最新文献

Therapeutic Advances in Urology最新文献

英文 中文
Hundred years of transperineal prostate biopsy. 经过会阴的百年前列腺活检。
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221100590
Benjamin Schmeusser, Brandon Levin, Daniel Lama, Abhinav Sidana

The earliest recorded efforts to biopsy prostate, in the early 20th century, were made through transperineal (TP) approach, with open perineal prostate biopsy (PBx) being considered the gold standard for prostate cancer (PCa) diagnosis in that era. Later, to minimize morbidity and increase diagnostic accuracy, several technical modifications and transrectal ultrasound (TRUS) assistance were incorporated. However, in the 1980s, the transrectal (TR) approach became the predominant PBx method following the introduction of TRUS-TR PBx with sextant sampling, providing a convenient and efficacious method for prostate sampling. With modernization of PCa diagnosis, a recent resurgence of the TP PBx has been observed, driven primarily by TR drawbacks of infectious complications and sampling limitations. TP PBx is rapidly emerging as the new PBx standard, being officially recommended as the initial approach for biopsy in Europe and is increasingly being conducted and studied in the United States. The modern era of TP PBx is based on the improvements in local anesthesia techniques, TP access systems, and robotic assistance. These modifications and advancements have improved the ease of use, patient comfort, and diagnostic outcomes with TP PBx. Herein, we present a history of the evolution of TP PBx spanning over 100 years and explore the basis of the technique that merits future utilization.

最早的前列腺活检记录是在20世纪初通过经会阴(TP)入路进行的,开放式会阴前列腺活检(PBx)被认为是那个时代前列腺癌(PCa)诊断的金标准。后来,为了减少发病率和提高诊断准确性,一些技术改进和经直肠超声(TRUS)辅助被纳入。然而,在20世纪80年代,随着带六分仪采样的TRUS-TR PBx的引入,经直肠(TR)入路成为主要的PBx方法,为前列腺采样提供了一种方便有效的方法。随着PCa诊断的现代化,TP PBx最近的复苏已经被观察到,主要是由于感染并发症和采样限制的TR缺点。TP PBx正在迅速成为新的PBx标准,在欧洲被正式推荐为活检的初始方法,在美国也越来越多地进行和研究。TP PBx的现代时代是基于局部麻醉技术、TP接入系统和机器人辅助的改进。这些改进和进步提高了TP PBx的易用性、患者舒适度和诊断结果。在此,我们介绍了TP PBx超过100年的发展历史,并探讨了该技术值得未来使用的基础。
{"title":"Hundred years of transperineal prostate biopsy.","authors":"Benjamin Schmeusser,&nbsp;Brandon Levin,&nbsp;Daniel Lama,&nbsp;Abhinav Sidana","doi":"10.1177/17562872221100590","DOIUrl":"https://doi.org/10.1177/17562872221100590","url":null,"abstract":"<p><p>The earliest recorded efforts to biopsy prostate, in the early 20th century, were made through transperineal (TP) approach, with open perineal prostate biopsy (PBx) being considered the gold standard for prostate cancer (PCa) diagnosis in that era. Later, to minimize morbidity and increase diagnostic accuracy, several technical modifications and transrectal ultrasound (TRUS) assistance were incorporated. However, in the 1980s, the transrectal (TR) approach became the predominant PBx method following the introduction of TRUS-TR PBx with sextant sampling, providing a convenient and efficacious method for prostate sampling. With modernization of PCa diagnosis, a recent resurgence of the TP PBx has been observed, driven primarily by TR drawbacks of infectious complications and sampling limitations. TP PBx is rapidly emerging as the new PBx standard, being officially recommended as the initial approach for biopsy in Europe and is increasingly being conducted and studied in the United States. The modern era of TP PBx is based on the improvements in local anesthesia techniques, TP access systems, and robotic assistance. These modifications and advancements have improved the ease of use, patient comfort, and diagnostic outcomes with TP PBx. Herein, we present a history of the evolution of TP PBx spanning over 100 years and explore the basis of the technique that merits future utilization.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":"14 ","pages":"17562872221100590"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/48/10.1177_17562872221100590.PMC9128053.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10306477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Inflammatory myofibroblastic tumour of the bladder: a case report and review of the literature 膀胱炎性肌成纤维细胞瘤1例报告及文献复习
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221096385
B. Marais, P. Eyal, K. Kesner, J. John
Inflammatory myofibroblastic tumours (IMTs) are rare neoplasms of uncertain malignant potential that closely resemble other more aggressive spindle cell tumours. The distinction of IMT from the latter is of importance. We report a case of IMT in a 27-year-old man who presented with intermittent painless, macroscopic haematuria and was found to have a large bladder mass arising from the dome of the bladder. The tumour was resected transurethrally, and histology and immunohistochemistry were consistent with an IMT of the bladder. Our patient remained asymptomatic at follow-up 3 months later, when cystoscopy noted no regrowth of the residual tumour. Transurethral resection resection of bladder tumour, partial cystectomy and radical cystectomy form the mainstay of treatment of IMT. However, the optimal management of this condition remains uncertain due to the sparsity of reported cases.
炎性肌成纤维细胞肿瘤(IMTs)是一种罕见的恶性潜能不确定的肿瘤,与其他侵袭性更强的梭形细胞肿瘤非常相似。IMT与后者的区别非常重要。我们报告了一例27岁男性的IMT,他表现为间歇性无痛、肉眼可见的血尿,并发现膀胱圆顶有一个大的膀胱肿块。肿瘤经尿道切除,组织学和免疫组织化学与膀胱IMT一致。我们的患者在随访3时仍无症状 几个月后,膀胱镜检查发现残余肿瘤没有再生。经尿道膀胱肿瘤切除术、部分膀胱切除术和根治性膀胱切除术是治疗IMT的主要方法。然而,由于报告病例的稀疏性,这种情况的最佳管理仍然不确定。
{"title":"Inflammatory myofibroblastic tumour of the bladder: a case report and review of the literature","authors":"B. Marais, P. Eyal, K. Kesner, J. John","doi":"10.1177/17562872221096385","DOIUrl":"https://doi.org/10.1177/17562872221096385","url":null,"abstract":"Inflammatory myofibroblastic tumours (IMTs) are rare neoplasms of uncertain malignant potential that closely resemble other more aggressive spindle cell tumours. The distinction of IMT from the latter is of importance. We report a case of IMT in a 27-year-old man who presented with intermittent painless, macroscopic haematuria and was found to have a large bladder mass arising from the dome of the bladder. The tumour was resected transurethrally, and histology and immunohistochemistry were consistent with an IMT of the bladder. Our patient remained asymptomatic at follow-up 3 months later, when cystoscopy noted no regrowth of the residual tumour. Transurethral resection resection of bladder tumour, partial cystectomy and radical cystectomy form the mainstay of treatment of IMT. However, the optimal management of this condition remains uncertain due to the sparsity of reported cases.","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44718827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Midline submuscular penile prosthesis reservoir placement for patients with bilateral inaccessible inguinal rings: technique and outcomes. 双侧腹股沟环不可达患者的阴茎肌下假体中线贮液:技术和结果。
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221139109
Ariel Zisman, Shirin Razdan, Alexandra Siegal, Michaela Sljivich, Christine Bieber, Patrick Ho, Robert Valenzuela

Introduction: One of the most challenging aspects of inflatable penile prosthesis (IPP) surgery is reservoir placement. The traditional space of Retzius (SOR) is not suitable for all patients. For example, radical cystectomy or prostatectomy may alter the anatomical SOR. Hence, traditional placement of the reservoir in this space increases the risk of bowel or vascular injury. Also, patients with bilateral inguinal hernias repaired with mesh, or those with previous reservoirs that have been retained, are not eligible for a Retzius reservoir. Our study reports on the use of midline sub-rectus muscle placement of a penile prosthesis reservoir in these patients as an alternative to high submuscular placement commonly used.

Methods: A retrospective chart review of male patients who underwent IPP surgery between June 2017 and 2021 was conducted. Patients were divided into two groups based on the location of the reservoir: SOR versus Midline Submuscular Reservoir (MSMR). Complication rates were compared, including herniated reservoirs, infections, bowel injuries, and vascular injuries.

Results: Our cohort included 461 patients who underwent IPP surgery between June 2017 and 2021 in one tertiary center. SOR was used in 89% of patients and MSMR in 11% of patients (n = 413 and 48, respectively). Median follow-up for all patients was 28 months. The mean age was 67 ± 8 years. There was no statistically significant difference between the two groups regarding age or comorbidities (BMI, diabetes mellitus, hypertension, hyperlipidemia, and coronary artery disease). The complication rate was low in both the SOR and MSMR groups, with device malfunction being the most common (2% versus 4%, respectively; p = 0.32). The infection rate was 0.5% in the SOR group with no infections in the MSMR group (NS). There was only one case of herniation requiring surgical revision in the SOR group and no cases of bowel or vascular injury.

Conclusion: Placement of a penile prosthesis reservoir within a midline rectus submuscular space is a safe and effective technique when the SOR is compromised by previous surgery or bilateral inguinal canals are not accessible.

简介:充气阴茎假体(IPP)手术中最具挑战性的方面之一是储层的放置。传统的Retzius (SOR)空间并不适合所有患者。例如,根治性膀胱切除术或前列腺切除术可改变解剖学上的SOR。因此,传统的储液器放置在这个空间会增加肠或血管损伤的风险。此外,双侧腹股沟疝经补片修复的患者,或先前有保留贮槽的患者,不适合使用Retzius贮槽。我们的研究报告了在这些患者中使用中线直下肌放置阴茎假体库,作为常用的高肌下放置的替代方法。方法:回顾性分析2017年6月至2021年接受IPP手术的男性患者。根据储藏库的位置将患者分为两组:SOR和中线肌下储藏库(MSMR)。比较并发症发生率,包括储层疝、感染、肠损伤和血管损伤。结果:我们的队列包括461名患者,他们于2017年6月至2021年在一个三级中心接受了IPP手术。89%的患者使用SOR, 11%的患者使用MSMR (n = 413和48)。所有患者的中位随访时间为28个月。平均年龄67±8岁。两组在年龄或合并症(BMI、糖尿病、高血压、高脂血症和冠状动脉疾病)方面无统计学差异。SOR组和MSMR组的并发症发生率都很低,器械故障是最常见的(分别为2%和4%;p = 0.32)。SOR组感染率为0.5%,MSMR组无感染(NS)。在SOR组中只有1例疝需要手术矫正,没有肠或血管损伤病例。结论:在直肌中线肌下间隙内放置阴茎假体是一种安全有效的技术,当SOR因既往手术受损或双侧腹股沟管无法到达时。
{"title":"Midline submuscular penile prosthesis reservoir placement for patients with bilateral inaccessible inguinal rings: technique and outcomes.","authors":"Ariel Zisman,&nbsp;Shirin Razdan,&nbsp;Alexandra Siegal,&nbsp;Michaela Sljivich,&nbsp;Christine Bieber,&nbsp;Patrick Ho,&nbsp;Robert Valenzuela","doi":"10.1177/17562872221139109","DOIUrl":"https://doi.org/10.1177/17562872221139109","url":null,"abstract":"<p><strong>Introduction: </strong>One of the most challenging aspects of inflatable penile prosthesis (IPP) surgery is reservoir placement. The traditional space of Retzius (SOR) is not suitable for all patients. For example, radical cystectomy or prostatectomy may alter the anatomical SOR. Hence, traditional placement of the reservoir in this space increases the risk of bowel or vascular injury. Also, patients with bilateral inguinal hernias repaired with mesh, or those with previous reservoirs that have been retained, are not eligible for a Retzius reservoir. Our study reports on the use of midline sub-rectus muscle placement of a penile prosthesis reservoir in these patients as an alternative to high submuscular placement commonly used.</p><p><strong>Methods: </strong>A retrospective chart review of male patients who underwent IPP surgery between June 2017 and 2021 was conducted. Patients were divided into two groups based on the location of the reservoir: SOR <i>versus</i> Midline Submuscular Reservoir (MSMR). Complication rates were compared, including herniated reservoirs, infections, bowel injuries, and vascular injuries.</p><p><strong>Results: </strong>Our cohort included 461 patients who underwent IPP surgery between June 2017 and 2021 in one tertiary center. SOR was used in 89% of patients and MSMR in 11% of patients (<i>n</i> = 413 and 48, respectively). Median follow-up for all patients was 28 months. The mean age was 67 ± 8 years. There was no statistically significant difference between the two groups regarding age or comorbidities (BMI, diabetes mellitus, hypertension, hyperlipidemia, and coronary artery disease). The complication rate was low in both the SOR and MSMR groups, with device malfunction being the most common (2% <i>versus</i> 4%, respectively; <i>p</i> = 0.32). The infection rate was 0.5% in the SOR group with no infections in the MSMR group (NS). There was only one case of herniation requiring surgical revision in the SOR group and no cases of bowel or vascular injury.</p><p><strong>Conclusion: </strong>Placement of a penile prosthesis reservoir within a midline rectus submuscular space is a safe and effective technique when the SOR is compromised by previous surgery or bilateral inguinal canals are not accessible.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":"14 ","pages":"17562872221139109"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/22/c1/10.1177_17562872221139109.PMC9730003.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10680985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
How did the first year of the COVID-19 pandemic affect urology practice in Arab countries? A cross-sectional study by the Arab Association of Urology research group 2019冠状病毒病大流行的第一年如何影响阿拉伯国家的泌尿外科实践?阿拉伯泌尿学研究协会的一项横断面研究group
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221079492
Y. Noureldin, B. Elmohamady, A. El-Dakhakhny, M. Omar, E. Desoky, Y. Ghazwani, S. B. Hamri, A. Alkhayal, K. Alrabeeah, W. Kamal, F. Farag, Y. Farahat
Objective: The aim of this study was to assess of the effect of coronavirus disease 2019 (COVID-19) pandemic on urology practice in the Arab world during the first year of the crisis. Methods: An Internet-based questionnaire was created and sent out via email to members of the Arab Association of Urology (AAU) using ‘Google Forms’. The survey assessed participants’ demographics in terms of age, gender, country of origin, type of practice and position. Impacts of COVID-19 on urological practice were assessed in terms of the changes in hospital policies regarding consultations, and elective and emergency surgical cases. Moreover, impacts of COVID-19 on urologists were assessed. Results: A total of 255 AAU members across 14 Arab countries (Emirates, Egypt, Saudi Arabia, Iraq, Jordan, Algeria, Kuwait, Yemen, Qatar, Lebanon, Libya, Oman, Sudan and Syria) completed the survey; 4% were female urologists. Consultations at outpatient clinics were closed or restricted to emergency cases or replaced by telemedicine in almost 15%, 40% and 25% of hospitals, respectively. Elective surgeries were stopped or reduced to under 25% of surgical capacity in >10% and about 25% of hospitals, respectively. Almost 90% (228) reported changes in the policy for emergency theatres. Nearly 65% of hospitals offered preoperative COVID-19 testing to patients and 50% of hospitals provided personal protective equipment (PPE) to their urologists. Of 99% (253) who reported a change in urological education, 95% relied on online webinars. About 56% of respondents had their own private practice, of whom 91% continued private practice during the crisis. About 38% of participants reported exposure to intimidation (75% emotional, 20% verbal and 5% physical). Conclusion: The COVID-19 pandemic resulted in major changes in hospitals’ policies regarding outpatient consultations, elective and emergency operative cases, and the shift to telemedicine. Arab urologists have been facing major challenges either in both the governmental or the private sectors, and some of them were exposed to emotional, verbal and even physical intimidation.
目的:本研究旨在评估2019冠状病毒病(新冠肺炎)大流行对危机第一年阿拉伯世界泌尿外科实践的影响。方法:制作一份基于互联网的问卷,并使用“谷歌表格”通过电子邮件发送给阿拉伯泌尿外科协会(AAU)的成员。该调查从年龄、性别、原籍国、执业类型和职位等方面评估了参与者的人口统计数据。评估了新冠肺炎对泌尿外科实践的影响,包括医院关于会诊、择期和紧急手术病例的政策变化。此外,还评估了新冠肺炎对泌尿科医生的影响。结果:共有来自14个阿拉伯国家(阿联酋、埃及、沙特阿拉伯、伊拉克、约旦、阿尔及利亚、科威特、也门、卡塔尔、黎巴嫩、利比亚、阿曼、苏丹和叙利亚)的255名AAU成员完成了调查;女性泌尿科医生占4%。分别有近15%、40%和25%的医院关闭了门诊咨询,或仅限于急诊,或被远程医疗取代。在>10%和约25%的医院,选择性手术被停止或减少到手术能力的25%以下。近90%(228)的人报告说,急诊室的政策发生了变化。近65%的医院为患者提供术前新冠肺炎检测,50%的医院为泌尿科医生提供个人防护设备(PPE)。在99%(253人)报告泌尿外科教育发生变化的人中,95%的人依靠在线网络研讨会。大约56%的受访者有自己的私人诊所,其中91%的人在危机期间继续私人诊所。约38%的参与者表示受到恐吓(75%是情绪上的,20%是言语上的,5%是身体上的)。结论:新冠肺炎大流行导致医院在门诊会诊、择期和急诊手术病例方面的政策发生重大变化,并转向远程医疗。阿拉伯泌尿科医生在政府或私营部门都面临着重大挑战,其中一些人受到了情感、言语甚至身体上的恐吓。
{"title":"How did the first year of the COVID-19 pandemic affect urology practice in Arab countries? A cross-sectional study by the Arab Association of Urology research group","authors":"Y. Noureldin, B. Elmohamady, A. El-Dakhakhny, M. Omar, E. Desoky, Y. Ghazwani, S. B. Hamri, A. Alkhayal, K. Alrabeeah, W. Kamal, F. Farag, Y. Farahat","doi":"10.1177/17562872221079492","DOIUrl":"https://doi.org/10.1177/17562872221079492","url":null,"abstract":"Objective: The aim of this study was to assess of the effect of coronavirus disease 2019 (COVID-19) pandemic on urology practice in the Arab world during the first year of the crisis. Methods: An Internet-based questionnaire was created and sent out via email to members of the Arab Association of Urology (AAU) using ‘Google Forms’. The survey assessed participants’ demographics in terms of age, gender, country of origin, type of practice and position. Impacts of COVID-19 on urological practice were assessed in terms of the changes in hospital policies regarding consultations, and elective and emergency surgical cases. Moreover, impacts of COVID-19 on urologists were assessed. Results: A total of 255 AAU members across 14 Arab countries (Emirates, Egypt, Saudi Arabia, Iraq, Jordan, Algeria, Kuwait, Yemen, Qatar, Lebanon, Libya, Oman, Sudan and Syria) completed the survey; 4% were female urologists. Consultations at outpatient clinics were closed or restricted to emergency cases or replaced by telemedicine in almost 15%, 40% and 25% of hospitals, respectively. Elective surgeries were stopped or reduced to under 25% of surgical capacity in >10% and about 25% of hospitals, respectively. Almost 90% (228) reported changes in the policy for emergency theatres. Nearly 65% of hospitals offered preoperative COVID-19 testing to patients and 50% of hospitals provided personal protective equipment (PPE) to their urologists. Of 99% (253) who reported a change in urological education, 95% relied on online webinars. About 56% of respondents had their own private practice, of whom 91% continued private practice during the crisis. About 38% of participants reported exposure to intimidation (75% emotional, 20% verbal and 5% physical). Conclusion: The COVID-19 pandemic resulted in major changes in hospitals’ policies regarding outpatient consultations, elective and emergency operative cases, and the shift to telemedicine. Arab urologists have been facing major challenges either in both the governmental or the private sectors, and some of them were exposed to emotional, verbal and even physical intimidation.","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48045831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
11th Emirates Urological Conference and 18th Pan Arab Continence Society Conference, 28–30 October 2022: Abstracts 第11届阿联酋泌尿外科会议和第18届泛阿拉伯失禁协会会议,2022年10月28日至30日:摘要
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221138220
{"title":"11th Emirates Urological Conference and 18th Pan Arab Continence Society Conference, 28–30 October 2022: Abstracts","authors":"","doi":"10.1177/17562872221138220","DOIUrl":"https://doi.org/10.1177/17562872221138220","url":null,"abstract":"","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49477155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive function in patients undergoing cystectomy for bladder cancer – results from a prospective observational study 膀胱癌膀胱切除术患者的认知功能——来自一项前瞻性观察研究的结果
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221087660
C. Grunewald, V. Feldmeier, T. Supprian, P. Albers, M. Giessing, G. Niegisch
Background: Impaired cognitive function of bladder cancer patients plays a role in coping with the kind of urinary diversion and may impact perioperative morbidity. In this study we therefore aimed to assess the prevalence of mild cognitive impairment in patients undergoing radical cystectomy. Secondary objectives included correlation of common cognition tests, assessment of the admitting physician, and perioperative complication rates. Methods: Patients undergoing radical cystectomy for bladder cancer were prospectively screened by neuropsychological tests including cognition tests [DemTect (Dementia Detection test), MMSE (Mini-Mental State Examination), clock drawing test] prior to surgery. Besides, clinical characteristics and perioperative outcomes were documented. Frequency of mild cognitive impairment as assessed by DemTect was correlated with the results of MMSE and clock drawing test, the occurrence of anxiety and depression, the assessment of the admitting physician, and perioperative complication rates as calculated by Spearman rank correlation coefficient. Comparative analysis (parametric and nonparametric) of patient characteristics (nonpathological versus pathological DemTect suggestive of mild cognitive impairment) was performed. Results: A total of 51 patients (80% male, median age 69 years) were analyzed. DemTect was suspicious of mild cognitive impairment in 27% (14/51) of patients, whereas MMSE and clock drawing test showed pathological results only in 10/51 and 6/51 patients, respectively. We found no correlation between mild cognitive impairment and anxiety/depression status. In all, 5/20 patients (25%) with suspicious DemTect results were considered suitable for a continent diversion neobladder by the admitting physician. Suspicious DemTect results were predictive for higher perioperative complication rates (29% versus 5%). Study limitations include small sample size and missing long-term follow-up. Conclusions: Mild cognitive impairment was observed in more than a quarter of radical cystectomy patients prior to surgery. Preoperative assessment should be supplemented by neuropsychological testing such as the DemTect as mild cognitive impairment is often underestimated and associated with significantly higher perioperative complication rates.
背景:癌症患者认知功能受损在应对尿路分流中起着重要作用,并可能影响围手术期的发病率。因此,在本研究中,我们旨在评估接受根治性膀胱切除术的患者中轻度认知障碍的患病率。次要目标包括常见认知测试的相关性、住院医师的评估和围手术期并发症发生率。方法:对癌症根治性膀胱切除术患者进行前瞻性筛选,包括术前认知测试[DemTect(痴呆检测测试),MMSE(最小精神状态检查),时钟绘制测试]。此外,还记录了临床特征和围手术期结果。DemTect评估的轻度认知障碍的频率与MMSE和时钟绘制测试的结果、焦虑和抑郁的发生率、入院医生的评估以及Spearman秩相关系数计算的围手术期并发症发生率相关。对患者特征(提示轻度认知障碍的非病理性与病理性DemTect)进行了比较分析(参数和非参数)。结果:共有51名患者(80%为男性,中位年龄69岁) 年)进行分析。DemTect在27%(14/51)的患者中怀疑轻度认知障碍,而MMSE和时钟描记测试分别仅在10/51和6/51的患者中显示病理结果。我们发现轻度认知障碍与焦虑/抑郁状态之间没有相关性。总的来说,有5/20名DemTect结果可疑的患者(25%)被入院医生认为适合进行大陆转移新膀胱术。可疑的DemTect结果可预测较高的围手术期并发症发生率(29%对5%)。研究的局限性包括样本量小和缺少长期随访。结论:超过四分之一的根治性膀胱切除术患者在手术前出现轻度认知障碍。术前评估应辅以神经心理测试,如DemTect,因为轻度认知障碍往往被低估,并与明显更高的围手术期并发症发生率相关。
{"title":"Cognitive function in patients undergoing cystectomy for bladder cancer – results from a prospective observational study","authors":"C. Grunewald, V. Feldmeier, T. Supprian, P. Albers, M. Giessing, G. Niegisch","doi":"10.1177/17562872221087660","DOIUrl":"https://doi.org/10.1177/17562872221087660","url":null,"abstract":"Background: Impaired cognitive function of bladder cancer patients plays a role in coping with the kind of urinary diversion and may impact perioperative morbidity. In this study we therefore aimed to assess the prevalence of mild cognitive impairment in patients undergoing radical cystectomy. Secondary objectives included correlation of common cognition tests, assessment of the admitting physician, and perioperative complication rates. Methods: Patients undergoing radical cystectomy for bladder cancer were prospectively screened by neuropsychological tests including cognition tests [DemTect (Dementia Detection test), MMSE (Mini-Mental State Examination), clock drawing test] prior to surgery. Besides, clinical characteristics and perioperative outcomes were documented. Frequency of mild cognitive impairment as assessed by DemTect was correlated with the results of MMSE and clock drawing test, the occurrence of anxiety and depression, the assessment of the admitting physician, and perioperative complication rates as calculated by Spearman rank correlation coefficient. Comparative analysis (parametric and nonparametric) of patient characteristics (nonpathological versus pathological DemTect suggestive of mild cognitive impairment) was performed. Results: A total of 51 patients (80% male, median age 69 years) were analyzed. DemTect was suspicious of mild cognitive impairment in 27% (14/51) of patients, whereas MMSE and clock drawing test showed pathological results only in 10/51 and 6/51 patients, respectively. We found no correlation between mild cognitive impairment and anxiety/depression status. In all, 5/20 patients (25%) with suspicious DemTect results were considered suitable for a continent diversion neobladder by the admitting physician. Suspicious DemTect results were predictive for higher perioperative complication rates (29% versus 5%). Study limitations include small sample size and missing long-term follow-up. Conclusions: Mild cognitive impairment was observed in more than a quarter of radical cystectomy patients prior to surgery. Preoperative assessment should be supplemented by neuropsychological testing such as the DemTect as mild cognitive impairment is often underestimated and associated with significantly higher perioperative complication rates.","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47339046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator 在前列腺MRI阴性的生物治疗和既往阴性活检男性中,临床显著前列腺癌症的预测因素:使用新型风险计算器改进基于MRI的筛查
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221088536
L. V. van Riel, A. Jager, D. Meijer, A. Postema, R. Smit, A. Vis, T. D. de Reijke, H. Beerlage, J. Oddens
Purpose: A pre-biopsy decision aid is needed to counsel men with a clinical suspicion for clinically significant prostate cancer (csPCa), despite normal prostate magnetic resonance imaging (MRI). Methods: A risk calculator (RC) for csPCa (International Society of Urological Pathology grade group (ISUP) ⩾ 2) presence in men with a negative-MRI (Prostate Imaging–Reporting and Data System (PI-RADS) ⩽ 2) was developed, and its performance was compared with RCs of the European Randomized Study of Screening for Prostate Cancer (ERSPC), Prostate Biopsy Collaborative Group (PBCG), and Prospective Loyola University mpMRI (PLUM). All biopsy-naïve and prior negative biopsy men with a negative-MRI followed by systematic prostate biopsy were included from October 2015 to September 2021. The RC was developed using multivariable logistic regression with the following parameters: age (years), family history of PCa (first- or second-degree family member), ancestry (African Caribbean/other), digital rectal exam (benign/malignant), MRI field strength (1.5/3.0 Tesla), prior negative biopsy status, and prostate-specific antigen (PSA) density (ng/ml/cc). Performance of RCs was compared using receiver operating characteristic (ROC) curve analysis. Results: A total of 232 men were included for analysis, of which 18.1% had csPCa. Parameters associated with csPCa were family history of PCa (p < 0.0001), African Caribbean ancestry (p = 0.005), PSA density (p = 0.002), prior negative biopsy (p = 0.06), and age at biopsy (p = 0.157). The area under the curve (AUC) of the developed RC was 0.76 (95% CI 0.68–0.85). This was significantly better than the RCs of the ERSPC (AUC: 0.59; p = 0.001) and PBCG (AUC: 0.60; p = 0.002), yet similar to PLUM (AUC: 0.69; p = 0.09). Conclusion: The developed RC (Prostate Biopsy Cohort Amsterdam (‘PROBA’ RC), integrated predictors for csPCa at prostate biopsy in negative-MRI men and outperformed other widely used RCs. These findings require external validation before introduction in daily practice.
目的:尽管前列腺磁共振成像(MRI)正常,但需要活检前的决策帮助来咨询临床上怀疑患有临床显著前列腺癌症(csPCa)的男性。方法:csPCa(国际泌尿病理学学会分级组(ISUP))的风险计算器(RC) ⩾ 2) MRI阴性男性的存在(前列腺成像-报告和数据系统(PI-RADS) ⩽ 2) 开发了,并将其性能与欧洲癌症筛查随机研究(ERSPC)、前列腺活检协作组(PBCG)和前瞻性洛约拉大学mpMRI(PLUM)的RC进行了比较。2015年10月至2021年9月,包括所有活检幼稚和之前MRI阴性、随后进行系统前列腺活检的阴性活检男性。RC是使用多变量逻辑回归开发的,参数如下:年龄(年)、前列腺癌家族史(一级或二级家族成员)、祖先(非洲加勒比/其他)、直肠指检(良性/恶性)、MRI场强(1.5/3.0特斯拉)、既往阴性活组织检查状态和前列腺特异性抗原(PSA)密度(ng/ml/cc)。使用受试者工作特性(ROC)曲线分析比较RC的性能。结果:共有232名男性被纳入分析,其中18.1%患有csPCa。与csPCa相关的参数为PCa家族史(p < 0.0001),非洲加勒比血统(p = 0.005),PSA密度(p = 0.002),既往活检阴性(p = 0.06)和活检时的年龄(p = 0.157)。开发的RC的曲线下面积(AUC)为0.76(95%CI 0.68–0.85)。这明显优于ERSPC的RC(AUC:0.59;p = 0.001)和PBCG(AUC:0.60;p = 0.002),但与PLUM相似(AUC:0.69;p = 0.09)。结论:所开发的RC(阿姆斯特丹前列腺活检队列(“PROBA”RC)是阴性MRI男性前列腺活检中csPCa的综合预测指标,并且优于其他广泛使用的RC。这些发现需要在日常实践中引入之前进行外部验证。
{"title":"Predictors of clinically significant prostate cancer in biopsy-naïve and prior negative biopsy men with a negative prostate MRI: improving MRI-based screening with a novel risk calculator","authors":"L. V. van Riel, A. Jager, D. Meijer, A. Postema, R. Smit, A. Vis, T. D. de Reijke, H. Beerlage, J. Oddens","doi":"10.1177/17562872221088536","DOIUrl":"https://doi.org/10.1177/17562872221088536","url":null,"abstract":"Purpose: A pre-biopsy decision aid is needed to counsel men with a clinical suspicion for clinically significant prostate cancer (csPCa), despite normal prostate magnetic resonance imaging (MRI). Methods: A risk calculator (RC) for csPCa (International Society of Urological Pathology grade group (ISUP) ⩾ 2) presence in men with a negative-MRI (Prostate Imaging–Reporting and Data System (PI-RADS) ⩽ 2) was developed, and its performance was compared with RCs of the European Randomized Study of Screening for Prostate Cancer (ERSPC), Prostate Biopsy Collaborative Group (PBCG), and Prospective Loyola University mpMRI (PLUM). All biopsy-naïve and prior negative biopsy men with a negative-MRI followed by systematic prostate biopsy were included from October 2015 to September 2021. The RC was developed using multivariable logistic regression with the following parameters: age (years), family history of PCa (first- or second-degree family member), ancestry (African Caribbean/other), digital rectal exam (benign/malignant), MRI field strength (1.5/3.0 Tesla), prior negative biopsy status, and prostate-specific antigen (PSA) density (ng/ml/cc). Performance of RCs was compared using receiver operating characteristic (ROC) curve analysis. Results: A total of 232 men were included for analysis, of which 18.1% had csPCa. Parameters associated with csPCa were family history of PCa (p < 0.0001), African Caribbean ancestry (p = 0.005), PSA density (p = 0.002), prior negative biopsy (p = 0.06), and age at biopsy (p = 0.157). The area under the curve (AUC) of the developed RC was 0.76 (95% CI 0.68–0.85). This was significantly better than the RCs of the ERSPC (AUC: 0.59; p = 0.001) and PBCG (AUC: 0.60; p = 0.002), yet similar to PLUM (AUC: 0.69; p = 0.09). Conclusion: The developed RC (Prostate Biopsy Cohort Amsterdam (‘PROBA’ RC), integrated predictors for csPCa at prostate biopsy in negative-MRI men and outperformed other widely used RCs. These findings require external validation before introduction in daily practice.","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47147546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Outcomes of ureteroscopy for management of stone disease in early and late childhood over a 15-year period. 15年期间输尿管镜治疗儿童早期和晚期结石疾病的结果
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221141775
Mriganka Sinha, Amelia Pietropaolo, Yesica Quiroz Madarriaga, Erika Llorens de Knecht, Anna Bujons Tur, Stephen Griffin, Bhaskar K Somani

Background: Although paediatric ureteroscopy is widely performed, there is still a lack of data and outcomes in early childhood. In this two-centre study, we compared the outcomes of ureteroscopy for stone disease management in early and late childhood and provide outcomes for the same.

Methods: Data was retrospectively collected on consecutive patients from two tertiary paediatric endo-urology European centres over a 15-year period (2006-2021). Patients were split into two groups, namely, early childhood (age ⩽ 9 years) and late childhood (age 9 to ⩽16 years). Outcomes including stone-free rate (SFR) and complications were compared between these two groups.

Results: A total of 148 patients underwent 184 procedures (1.2 procedure/patient) during the study period (66 in early childhood and 82 in late childhood). The mean age in early and late childhood groups were 5.6 and 13.3 years, and a male: female ratio of 1.6:1 and 1.1:1, respectively. The SFR and complications in early and late childhood groups were 87.8% and 90.2% (p = 0.64) and 5.7% and 4.1%, respectively.

Conclusion: Paediatric ureteroscopy and laser stone fragmentation achieves good results in both early and late childhood with comparable SFRs, although the complications and need for second procedure were marginally higher in the early childhood group. Our study would set up a new benchmark for patient counselling in future, and perhaps this needs to be reflected in the paediatric urolithiasis guidelines.

背景:虽然儿科输尿管镜检查被广泛应用,但在儿童早期仍然缺乏数据和结果。在这项双中心研究中,我们比较了输尿管镜治疗儿童早期和晚期结石疾病的结果,并提供了相同的结果。方法:回顾性收集来自欧洲两所三级儿科泌尿外科中心15年(2006-2021年)的连续患者的数据。患者分为两组,即儿童早期(年龄≥9岁)和儿童晚期(年龄≥9 ~ 16岁)。比较两组患者的无结石率(SFR)和并发症。结果:在研究期间,共有148名患者接受了184次手术(1.2次/患者)(66例儿童早期,82例儿童晚期)。儿童早期组和儿童晚期组的平均年龄分别为5.6岁和13.3岁,男女比例分别为1.6:1和1.1:1。儿童期早期和晚期组SFR和并发症发生率分别为87.8%和90.2% (p = 0.64)和5.7%和4.1%。结论:儿童输尿管镜和激光结石碎裂术在儿童期早期和晚期均取得了良好的效果,但早期组的并发症和第二次手术的需求略高。我们的研究将为未来的患者咨询建立一个新的基准,也许这需要在儿科尿石症指南中得到反映。
{"title":"Outcomes of ureteroscopy for management of stone disease in early and late childhood over a 15-year period.","authors":"Mriganka Sinha,&nbsp;Amelia Pietropaolo,&nbsp;Yesica Quiroz Madarriaga,&nbsp;Erika Llorens de Knecht,&nbsp;Anna Bujons Tur,&nbsp;Stephen Griffin,&nbsp;Bhaskar K Somani","doi":"10.1177/17562872221141775","DOIUrl":"https://doi.org/10.1177/17562872221141775","url":null,"abstract":"<p><strong>Background: </strong>Although paediatric ureteroscopy is widely performed, there is still a lack of data and outcomes in early childhood. In this two-centre study, we compared the outcomes of ureteroscopy for stone disease management in early and late childhood and provide outcomes for the same.</p><p><strong>Methods: </strong>Data was retrospectively collected on consecutive patients from two tertiary paediatric endo-urology European centres over a 15-year period (2006-2021). Patients were split into two groups, namely, early childhood (age ⩽ 9 years) and late childhood (age 9 to ⩽16 years). Outcomes including stone-free rate (SFR) and complications were compared between these two groups.</p><p><strong>Results: </strong>A total of 148 patients underwent 184 procedures (1.2 procedure/patient) during the study period (66 in early childhood and 82 in late childhood). The mean age in early and late childhood groups were 5.6 and 13.3 years, and a male: female ratio of 1.6:1 and 1.1:1, respectively. The SFR and complications in early and late childhood groups were 87.8% and 90.2% (<i>p</i> = 0.64) and 5.7% and 4.1%, respectively.</p><p><strong>Conclusion: </strong>Paediatric ureteroscopy and laser stone fragmentation achieves good results in both early and late childhood with comparable SFRs, although the complications and need for second procedure were marginally higher in the early childhood group. Our study would set up a new benchmark for patient counselling in future, and perhaps this needs to be reflected in the paediatric urolithiasis guidelines.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":"14 ","pages":"17562872221141775"},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/40/d3/10.1177_17562872221141775.PMC9772971.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10785253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is there a role for stem cell therapy in erectile dysfunction secondary to cavernous nerve injury? Network meta-analysis from animal studies and human trials 干细胞治疗在海绵状神经损伤后的勃起功能障碍中有作用吗?动物研究和人体试验的网络荟萃分析
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221086999
Mudassir M. Wani, B. Rai, W. R. Webb, S. Madaan
Introduction: We carried out systematic review and network meta-analysis to investigate the role of stem cell therapy (SCT) in the management of erectile dysfunction (ED) secondary to cavernous nerve injury in rats and post-radical prostatectomy (RP) in humans. Patients and Methods: The protocol was registered with PROSPERO database. We searched studies analyzing the efficacy of SCT for ED due to bilateral cavernous nerve injury (BCNI) in rats using Healthcare Databases Advanced Search (HDAS) Export software (MEDLINE, EMBASE, Scopus) from inception to September 2020. The outcome measurements, for 29 animal studies, were intracavernosal pressure (ICP), ICP/MAP (mean arterial pressure) ratio, and histological/molecular changes. All three available human trials evaluating SCT in post-RP ED were assessed for International Index for Erectile Function (IIEF) Score and Erection Hardness Score (EHS). Results: For ICP measurement, animal studies were divided into adipose-derived stem cells (ADSCs) subgroup and bone marrow–derived stem cells (BMSCs) subgroup. Pooled analysis of these studies showed a beneficial effect of SCT in improving erectile function in rats with BCNI using network meta-analysis (95% confidence interval, CI; p < 0.001). There was an increase in ICP/MAP ratio in stem cell groups (including co-intervention) compared with control BCNI group. Histological and molecular evaluation of penile tissue revealed an increase in neuronal nitric oxide synthase (nNOS), smooth muscle content, and anti-apoptotic activity. Human trials revealed improved IIEF (70–150% from baseline at 6 months) and EHS (80–200% from baseline). Conclusion: Our results confirm that SCT does improve the erectile function in rats having cavernous nerve injury. Similarly, early human results have shown promising results. PROSPERO registration ID: CRD42020201343.
我们进行了系统回顾和网络荟萃分析,以研究干细胞治疗(SCT)在大鼠海绵状神经损伤继发勃起功能障碍(ED)和人类根治性前列腺切除术(RP)后的治疗中的作用。患者和方法:该方案在PROSPERO数据库中注册。我们使用医疗数据库高级搜索(HDAS)输出软件(MEDLINE, EMBASE, Scopus)从成立到2020年9月检索了分析SCT治疗双侧海绵状神经损伤(BCNI)所致大鼠ED疗效的研究。在29项动物研究中,结果测量包括海膜内压(ICP)、ICP/MAP(平均动脉压)比和组织学/分子变化。所有三个可用的人体试验评估了SCT在rp后ED中的应用,评估了国际勃起功能指数(IIEF)评分和勃起硬度评分(EHS)。结果:为了测量ICP,动物研究被分为脂肪来源干细胞(ADSCs)亚组和骨髓来源干细胞(BMSCs)亚组。通过网络荟萃分析,对这些研究进行汇总分析,发现SCT对BCNI大鼠的勃起功能有改善作用(95%置信区间,CI;p < 0.001)。与BCNI对照组相比,干细胞组(包括联合干预组)ICP/MAP比值升高。阴茎组织的组织学和分子评价显示神经元一氧化氮合酶(nNOS)、平滑肌含量和抗凋亡活性增加。人体试验显示IIEF(6个月时较基线提高70-150%)和EHS(较基线提高80-200%)得到改善。结论:SCT可改善海绵体神经损伤大鼠的勃起功能。同样,早期的人体实验结果也显示出了令人鼓舞的结果。普洛斯彼罗注册ID: CRD42020201343。
{"title":"Is there a role for stem cell therapy in erectile dysfunction secondary to cavernous nerve injury? Network meta-analysis from animal studies and human trials","authors":"Mudassir M. Wani, B. Rai, W. R. Webb, S. Madaan","doi":"10.1177/17562872221086999","DOIUrl":"https://doi.org/10.1177/17562872221086999","url":null,"abstract":"Introduction: We carried out systematic review and network meta-analysis to investigate the role of stem cell therapy (SCT) in the management of erectile dysfunction (ED) secondary to cavernous nerve injury in rats and post-radical prostatectomy (RP) in humans. Patients and Methods: The protocol was registered with PROSPERO database. We searched studies analyzing the efficacy of SCT for ED due to bilateral cavernous nerve injury (BCNI) in rats using Healthcare Databases Advanced Search (HDAS) Export software (MEDLINE, EMBASE, Scopus) from inception to September 2020. The outcome measurements, for 29 animal studies, were intracavernosal pressure (ICP), ICP/MAP (mean arterial pressure) ratio, and histological/molecular changes. All three available human trials evaluating SCT in post-RP ED were assessed for International Index for Erectile Function (IIEF) Score and Erection Hardness Score (EHS). Results: For ICP measurement, animal studies were divided into adipose-derived stem cells (ADSCs) subgroup and bone marrow–derived stem cells (BMSCs) subgroup. Pooled analysis of these studies showed a beneficial effect of SCT in improving erectile function in rats with BCNI using network meta-analysis (95% confidence interval, CI; p < 0.001). There was an increase in ICP/MAP ratio in stem cell groups (including co-intervention) compared with control BCNI group. Histological and molecular evaluation of penile tissue revealed an increase in neuronal nitric oxide synthase (nNOS), smooth muscle content, and anti-apoptotic activity. Human trials revealed improved IIEF (70–150% from baseline at 6 months) and EHS (80–200% from baseline). Conclusion: Our results confirm that SCT does improve the erectile function in rats having cavernous nerve injury. Similarly, early human results have shown promising results. PROSPERO registration ID: CRD42020201343.","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":"14 1","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41557334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study 手术提高膀胱印戒细胞癌的生存率——一项基于人群的研究
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2022-01-01 DOI: 10.1177/17562872221079473
Mohammed Alradhi, M. Safi, S. Tao, Abdullah Al-danakh, Marwan Almoiliqy, S. Baldi, Xiancheng Li
Objectives: The purpose of this study is to determine the therapeutic value of surgery in individuals with urinary bladder signet ring cell carcinoma (SRCC). Surgery has not been examined as a prognostic factor for urinary bladder cancer (SRCC). Materials and Methods: Using the Surveillance, Epidemiology, and End Results program (SEER), patients with urinary bladder SRCC who presented from 1975 to 2018 were included in a retrospective study. The effect of surgical therapy on cause-specific survival (CSS) and overall survival (OS) was examined using univariate and multivariate Cox regression models. We subdivided 595 patients with SRCC into 2 groups, as follows: 496 who underwent surgery; and 99 who did not undergo surgery. Results: Males had high predominance in all cases in both groups (p = 0.04). Moderate and poor differentiation (III–IV) were observed in the majority of patients who underwent surgery (77.2 vs 58.6, p ⩽ 0.001) and had no insurance (p ⩽ 0.001). By using KM, the OS and CSS of the surgery group were found to be significantly better than those of the non-surgery group (p  = 0.001,%) after adjusting for the variables of age, race, sex, primary site, grade, stage, lymph node removal, chemotherapy record, radiotherapy record, insurance, and marital status in the multivariate Cox proportional hazard model (hazard ratio [HR]= 0. 592; 95% confidence interval [CI] = 0.449–0.782; p = 0.0001). In comparison with chemotherapy and radiation, which resulted in poorer survival rates, surgery considerably improved survival outcomes in urinary bladder SRCC. The nomogram prediction model was built with C-index values of 0.70 and 73 for OS and CSS prediction, respectively. AUC in OS values were 0.77, 0.76, and 0.74, whereas AUC in CSS were 0.83, 0.80, and 0.79 for the 1-, 3-, and 5-year survival nomograms, respectively. Conclusion: Surgery was a significant independent predictor of bladder SRCC survival. Patients who underwent surgery had higher CSS and OS than people who did not undergo surgery. Surgery also led to better survival than the combination of the different treatment modalities.
目的:本研究的目的是确定手术治疗膀胱印戒细胞癌(SRCC)的价值。手术作为膀胱癌(SRCC)的预后因素尚未被研究。材料和方法:使用监测、流行病学和最终结果项目(SEER),将1975年至2018年出现的膀胱SRCC患者纳入回顾性研究。采用单因素和多因素Cox回归模型检查手术治疗对病因特异性生存(CSS)和总生存(OS)的影响。我们将595例SRCC患者再分为两组:496例接受手术治疗;还有99人没有接受手术。结果:两组病例均以男性为主(p = 0.04)。在大多数接受手术的患者(77.2 vs 58.6, p < 0.001)中观察到中度和低分化(III-IV),并且没有保险(p < 0.001)。在多变量Cox比例风险模型中,经年龄、种族、性别、原发部位、分级、分期、淋巴结切除、化疗记录、放疗记录、保险、婚姻状况等因素校正后,采用KM方法,发现手术组的OS和CSS显著优于非手术组(p = 0.001,%)(风险比[HR]= 0。592;95%置信区间[CI] = 0.449-0.782;p = 0.0001)。化疗和放疗的生存率较低,相比之下,手术显著提高了膀胱SRCC的生存率。建立nomogram预测模型,OS和CSS预测的c指数分别为0.70和73。OS值的AUC分别为0.77、0.76和0.74,而1年、3年和5年生存图的CSS AUC分别为0.83、0.80和0.79。结论:手术是膀胱SRCC生存的重要独立预测因素。接受手术的患者比未接受手术的患者有更高的CSS和OS。手术也比不同治疗方式的组合带来更好的生存。
{"title":"Surgery improves survival in bladder signet-ring cell carcinoma-a population-based study","authors":"Mohammed Alradhi, M. Safi, S. Tao, Abdullah Al-danakh, Marwan Almoiliqy, S. Baldi, Xiancheng Li","doi":"10.1177/17562872221079473","DOIUrl":"https://doi.org/10.1177/17562872221079473","url":null,"abstract":"Objectives: The purpose of this study is to determine the therapeutic value of surgery in individuals with urinary bladder signet ring cell carcinoma (SRCC). Surgery has not been examined as a prognostic factor for urinary bladder cancer (SRCC). Materials and Methods: Using the Surveillance, Epidemiology, and End Results program (SEER), patients with urinary bladder SRCC who presented from 1975 to 2018 were included in a retrospective study. The effect of surgical therapy on cause-specific survival (CSS) and overall survival (OS) was examined using univariate and multivariate Cox regression models. We subdivided 595 patients with SRCC into 2 groups, as follows: 496 who underwent surgery; and 99 who did not undergo surgery. Results: Males had high predominance in all cases in both groups (p = 0.04). Moderate and poor differentiation (III–IV) were observed in the majority of patients who underwent surgery (77.2 vs 58.6, p ⩽ 0.001) and had no insurance (p ⩽ 0.001). By using KM, the OS and CSS of the surgery group were found to be significantly better than those of the non-surgery group (p  = 0.001,%) after adjusting for the variables of age, race, sex, primary site, grade, stage, lymph node removal, chemotherapy record, radiotherapy record, insurance, and marital status in the multivariate Cox proportional hazard model (hazard ratio [HR]= 0. 592; 95% confidence interval [CI] = 0.449–0.782; p = 0.0001). In comparison with chemotherapy and radiation, which resulted in poorer survival rates, surgery considerably improved survival outcomes in urinary bladder SRCC. The nomogram prediction model was built with C-index values of 0.70 and 73 for OS and CSS prediction, respectively. AUC in OS values were 0.77, 0.76, and 0.74, whereas AUC in CSS were 0.83, 0.80, and 0.79 for the 1-, 3-, and 5-year survival nomograms, respectively. Conclusion: Surgery was a significant independent predictor of bladder SRCC survival. Patients who underwent surgery had higher CSS and OS than people who did not undergo surgery. Surgery also led to better survival than the combination of the different treatment modalities.","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":" ","pages":""},"PeriodicalIF":2.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42523101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Therapeutic Advances in Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1